Hemolytic uremic syndrome in association with typhoid fever

American Journal of Kidney Diseases

Volumn 41, Issue 3, 2003, Pages 709-713

  Albaqali, Ali ^b   Ghuloom, Adel ^b   Al Arrayed, Ahmed ^b   Al Ajami, Abdulla ^b   Shome, Durjoy K ^b   Jamsheer, Afaf ^b   Al Mahroos, Hyat ^b   Jelacic, Srdjan ^b   Tarr, Phillip I ^b   Kaplan, Bernard S ^b   Dhiman, Radha K ^a  

^a SALMANIYA MEDICAL COMPLEX   (Bahrain)

^b NONE

Author keywords

Hemolytic uremic syndrome (HUS); Myocarditis; Salmonella typhi; Shiga toxin; Typhoid fever

Indexed keywords

IMMUNOGLOBULIN M; SHIGA TOXIN;

ADULT; AGAR GEL ELECTROPHORESIS; ANTIBODY DETECTION; ARTICLE; BACTERIUM ISOLATION; BLOOD SAMPLING; CASE REPORT; DISEASE ASSOCIATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; MALE; MYOCARDITIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 0037373815     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50135     Document Type: Article

References (24)

1. Kaplan BS, Meyers KE, Schulman SL: The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9:1126-1133, 1998
2. O'Loughlin EV, Robins-Browne RM: Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3:493-507, 2001
3. Chaturvedi P. Dey SK, Agrawal M: Hemolytic-uremic syndrome associated with Salmonella typhi. Indian Pediatr 27:209-210. 1990
4. Baker NM, Mills AE, Rachman I, Thomas JE: Haemolytic-uraemic syndrome in typhoid fever. BMJ 2:84-87, 1974
5. Flores FX, Jabs K, Thome GM, Jaeger J, Linshaw MA, Somers MJ: Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis. Pediatr Nephrol 11:488-490, 1997
6. Raoult D, Dasch GA: The line blot: An immunoassay for monoclonal and other antibodies. Its application to the serotyping of gram-negative bacteria. J Immunol Methods 125:57-65, 1989
7. Sambrook J, Fritsch EF: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982
8. Jelacic S, Wobbe CL, Boster DR, et al: ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis 185:214-219, 2002
9. Hirose K, Itoh K, Nakajima H, et al: Selective amplification of tyv (rfbE), prt (rfbS), viaB, and fliC genes by multiplex PCR for identification of Salmonella enterica serovars Typhi and Paratyphi A. J Clin Microbiol 40:633-636, 2002
10. Bokete TN, Whittam TS, Wilson RA, et al: Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children. J Infect Dis 175:1382-1389, 1997
11. Tarr PI, Neill MA, Clausen CR, Newland JW, Neill RJ, Moseley SL: Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J Infect Dis 159:344-347, 1989
12. Katz J, Lurie A, Kaplan BS, Krawitz S, Metz J: Coagulation findings in the hemolytic-uremic syndrome of infancy: similarity to hyperacute renal allograft rejection. J Pediatr 78:426-434, 1971
13. Karch H, Meyer T, Russmann H, Heesemann J: Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun 60:3464-3467, 1992
14. McCleery DR, Rowe MT: Development of a model meat system and investigation of the growth characteristics and genetic stability of Escherichia coli O157:H7 in the absence of meat microflora. J Microbiol Methods 49:135-145, 2002
15. Karch H, Russmann H, Schmidt H, Schwarzkopf A, Heesemann J: Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli 0157 in diarrheal diseases. J Clin Microbiol 33:1602-1605, 1995
16. Brandt J, Wong C, Mihm S, et al: Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 110:371-376, 2002
17. Ludwig K, Bitzan M, Bobrowski C, Muller-Wiefel DE: Escherichia coli 0157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome. J Infect Dis 186:566-569, 2002
18. Feng P, Lampel KA, Karch H, Whittam TS: Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis 177:1750-1753, 1998
19. Vedanarayanan VV, Kaplan BS, Fong JS: Neutrophil function in an experimental model of hemolytic uremic syndrome. Pediatr Res 21:252-256, 1987
20. Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr: Response to Shiga toxin-1, with and without lipopolysaccharide in a primate model of hemolytic uremic syndrome. Am J Nephrol 21:420-425, 2001
21. Sharma A, Gathwala G: Clinical profile and outcome in enteric fever. Indian Pediatr 30:47-50, 1993
22. Prabha A, Mohanan, Pereira P, Raghuveer CV: Myocarditis in enteric fever. Indian J Med Sci 49:28-31, 1995
23. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI: The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930-1936, 2000
24. Tsai HM, Chandler WL, Sarode R, et al: von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49:653-659, 2001